Abstract:Abnormal spindle-like microcephaly-associated (ASPM) protein is essential for mitotic spindle function during cell replication. The present study aimed to evaluate the hypothesis that ASPM serves a critical role in cancer invasiveness and may act as a prognostic biomarker in bladder cancer. In total, 6 independent worldwide bladder cancer microarray mRNA expression datasets (n=1,355) with clinical and follow-up annotations were collected from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Reverse transcription-quantitative polymerase chain reaction analysis revealed that ASPM mRNA expression was higher in bladder cancer tissue compared with adjacent normal bladder mucosae in 10 paired human tissue samples (P=0.004). ASPM overexpression in human bladder cancer samples was consistent with the mRNA expression datasets from GEO and TCGA. Bioinformatics analysis indicated that ASPM mRNA expression was significantly associated with grade and tumor node metastasis (TNM) stage in bladder cancer, based on pooled GEO and TCGA datasets (P<0.05). Stratification analysis indicated that the clinical significance of ASPM was particularly pronounced in low-grade or papillary subtypes of bladder cancer. Individual Cox and pooled Kaplan-Meier analyses suggested that ASPM expression was significantly directly correlated with poor overall (OS) and progression-free survival (PFS) in bladder cancer. Multivariate and stratification analyses demonstrated that the prognostic significance of ASPM was evident in low-grade or papillary bladder cancers, yet not in high-grade or non-papillary subgroups. Increased expression of ASPM was associated with poor OS in muscle-invasive bladder cancer and with poor PFS in non-muscle-invasive bladder cancer (P<0.05). Bioinformatics analysis identified the top 11 ASPM-related genes on STRING-DB.org. The expression of the majority of these genes was associated with poor outcomes of bladder cancer with statistical significance. Gene set enrichment analysis indicated that the high expression of ASPM could enrich gene signatures involved in mitosis, differentiation and metastasis in bladder cancer. Further analysis of TCGA datasets indicated that increased ASPM expression was significantly associated with higher Gleason score, T stage, N stage and poor clinical outcome in prostate cancer. It was also significantly associated with late TNM stage and poor PFS in renal cell carcinoma. In summary, ASPM may serve as a novel prognostic biomarker for low-grade or papillary bladder cancer.

Genetic Variation in the Prostate Stem Cell Antigen Gene PSCA Confers Susceptibility to Urinary Bladder Cancer

Common Genetic Variants in the PSCA Gene Influence Gene Expression and Bladder Cancer Risk

Correction: Corrigendum: Genetic Variation in the Prostate Stem Cell Antigen Gene PSCA Confers Susceptibility to Urinary Bladder Cancer

Contribution of Prostate Stem Cell Antigen Variation Rs2294008 to the Risk of Bladder Cancer

A Genetic Study and Meta-Analysis of the Genetic Predisposition of Prostate Cancer in a Chinese Population

Overexpression of the ASPM Gene is Associated with Aggressiveness and Poor Outcome in Bladder Cancer.

PSCA Rs 2294008 C T Polymorphism Contributes to Gastric and Bladder Cancer Risk

Expression of PSCA protein in human bladder urothelial cancer and its clinical significance

Psca Polymorphisms and Gastric Cancer Susceptibility in an Eastern Chinese Population

Genetic Variation of PSCA Gene is Associated with the Risk of Both Diffuse‐ and Intestinal‐type Gastric Cancer in a Chinese Population

Alternative polyadenylation-related genetic variants contribute to bladder cancer risk

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

PSCA S2294008 C>T and Rs2976392 G>A Polymorphisms Contribute to Cancer Susceptibility: Evidence from Published Studies

Quantitative Assessment of the Influence of Prostate Stem Cell Antigen Polymorphisms on Gastric Cancer Risk

Effects of PSCA Rs 2294008 ( C / T ) and C-Myc Rs 9642880 ( G / T ) Polymorphisms on Bladder Cancer : Evidence from a Meta-Analysis

Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk

Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study

Genetic Variants of the Wnt Signaling Pathway As Predictors of Aggressive Disease and Reclassification in Men with Early Stage Prostate Cancer on Active Surveillance.

Association of Prostate Cancer Risk with SNPs in Regions Containing Androgen Receptor Binding Sites Captured by ChIP-On-chip Analyses.

Genome-Wide Association Study Identifies Multiple Loci Associated with Bladder Cancer Risk

Genetic Variations In Regulator Of G-Protein Signaling (Rgs) Confer Risk Of Bladder Cancer